CVS Health Corporation ($CVS) Stock Forecast: Up 5.0% Today

What is CVS Health Corporation?

CVS Health Corp (CVS) is a diversified healthcare company that operates pharmacy benefits, retail pharmacies, and health insurance services. Today, the stock experienced a strong bullish movement.

Why is CVS Health Corporation going up?

CVS stock is up 5.0% on May 13, 2026 13:51

• The announcement of successful weight-loss program at CVS clinics, with 85% of patients shedding pounds in 3 months, likely contributed to positive investor sentiment.
• Strong Q1 earnings results, surpassing analyst expectations with revenues of $100.43 billion and adjusted EPS of $2.57, along with raised full-year guidance, boosted confidence in CVS Health Corp's performance.
• The overall positive sentiment in the health insurance sector, as indicated by easing medical costs for major players like CVS, could have further supported the bullish movement in CVS stock.
• Despite the stock being deemed overvalued, the positive news regarding the company's initiatives and financial performance outweighed concerns about valuation, driving the stock price higher.

CVS Price Chart

CVS Technical Analysis

CVS News

CVS clinics say 85% of weight-loss patients shed pounds in 3 months

MinuteClinic, part of CVS, announced strong outcomes for its clinically supervised weight-loss program, with 85% of patients losing weight within three months and approximately two-thirds losing over 5% of their body weight after five or more months. The program, available in 49 states and DC, emphasizes accessible care through in-person and virtual visits, with 95% of patients having their first visit within one week of scheduling. This initiative aims to address chronic conditions linked to metabolic health, potentially including FDA-approved GLP-1 medications when appropriate, and represents CVS Health's strategy to expand access and care management.

https://www.stocktitan.net/news/CVS/minute-clinic-highlights-access-and-outcomes-in-clinically-soi9jx4ajz15.html

CVS Health Corp stock (US1266501006): Up 3.31% on strong Q1 earnings and raised guidance

CVS Health Corp's stock surged 3.31% following stronger-than-expected Q1 2026 earnings, with revenues of $100.43 billion and adjusted EPS of $2.57, well above analyst forecasts. The company also raised its full-year 2026 guidance, boosting investor confidence. CVS Health operates an integrated healthcare model combining pharmacy benefits, retail pharmacies, and health insurance, positioning it as a defensive play in the healthcare sector.

https://www.ad-hoc-news.de/boerse/news/ueberblick/cvs-health-corp-stock-us1266501006-up-3-31-percent-on-strong-q1/69323123

‘Glimmers of hope’ seen for insurers as medical costs abate

The health insurance sector is showing signs of recovery after several challenging years, as major insurers like UnitedHealth, CVS, and Cigna report an easing of medical costs. This development suggests a potential positive shift for the industry. The article highlights these "glimmers of hope" as observed in recent earnings reports from key players.

https://www.modernhealthcare.com/insurance/mh-unitedhealth-cvs-cigna-earnings-medical-costs/

Centene Corp. stock outperforms competitors on strong trading day

Centene Corp. (CNC) stock saw a positive trading day, outperforming its competitors. The stock closed at $78.07, marking a 1.25% gain, while the S&P 500 also rose.

https://www.msn.com/en-us/money/topstocks/centene-corp-stock-outperforms-competitors-on-strong-trading-day/ar-AA231JSK

CVS Health Corp (CVS) Stock Up 5.1% but GF Value Says Overvalued -- GF Score: 81/100

CVS Health Corp's stock rose 5.1% to $95.15, but GuruFocus's GF Value assesses it as 22.6% overvalued, with a GF Value™ of $77.63. Despite a strong GF Score™ of 81/100, indicating solid fundamentals, insiders have sold $6.2 million worth of shares, suggesting a lack of confidence. The current P/E ratio of 41.9x is significantly higher than its historical median, reinforcing the overvaluation concern.

https://www.gurufocus.com/news/8852729/cvs-health-corp-cvs-stock-up-51-but-gf-value-says-overvalued-gf-score-81100

Trending Today

Regal Beloit Corporation ($RBC) Stock Forecast: Down 5.3% Today

Amcor plc ($AMCR) Stock Forecast: Down 5.0% Today

DexCom Inc. ($DXCM) Stock Forecast: Up 5.7% Today

Wix.com Ltd. ($WIX) Stock Forecast: Up 5.1% Today

Marathon Digital Holdings Inc. ($MARA) Stock Forecast: Down 5.2% Today

Super Micro Computer Inc ($SMCI) Stock Forecast: Down 5.3% Today

Shiba Inu ($SHIB) Crypto Forecast: Down 5.0% Today

Jetblue Airways Corporation ($JBLU) Stock Forecast: Down 5.0% Today

IPG Photonics Corporation ($IPGP) Stock Forecast: Down 5.3% Today

Quidelortho Corpoation ($QDEL) Stock Forecast: Down 5.6% Today

CVS Health Corporation Price History

07.03.2026 - CVS Stock was up 6.9%

• CVS stock experienced a bullish movement following a decision to significantly raise Medicare insurer payments, benefiting companies in the healthcare sector.
• The increase in Medicare Advantage rates for 2027, as announced by a relevant government agency, contributed to the positive sentiment surrounding CVS and other insurance stocks.
• CVS's strong Q4 results, surpassing EPS and revenue estimates, along with a new investment from a prominent investor, further boosted investor confidence in the company's growth prospects.
• The overall bullish trend in healthcare stocks, particularly those involved in Medicare Advantage, indicates a positive outlook for CVS and its peers in the industry.

07.03.2026 - CVS Stock was up 6.2%

• CVS stock experienced a strong bullish movement, surging over 6% following positive news regarding 2027 Medicare Advantage rates, which were higher than expected.
• The surge in CVS stock can be attributed to the announcement of a significant increase in Medicare Advantage payments for 2027 by the Centers for Medicare & Medicaid Services (CMS).
• The decision to raise Medicare insurer payments was a result of extensive lobbying from the private insurance industry, leading to a boost in investor confidence in companies with exposure to managed care and health insurance.
• Analysts view CVS as undervalued, with expectations of further upside due to improved Medicare Advantage margins and cost-cutting initiatives, indicating a positive outlook for the company's ongoing turnaround efforts.

07.03.2026 - CVS Stock was up 6.6%

• CVS Health Corp. shares surged over 7% as a result of the more favorable than anticipated 2027 Medicare Advantage rates, indicating growing investor confidence in the company's turnaround efforts.
• The positive outlook on Medicare Advantage rates provided relief to investors and boosted CVS's stock, highlighting the company's potential for improved margins and cost-cutting initiatives.
• The favorable rate update, along with the overall positive sentiment in the managed care sector, contributed to the bullish movement in CVS's stock as investors see the company as undervalued with significant upside potential.
• The announcement by the Centers for Medicare & Medicaid Services (CMS) regarding increased Medicare Advantage payments for 2027 not only benefited CVS but also had a positive impact on other major healthcare companies like UnitedHealth and Humana, signaling stability and revenue visibility in the MA market.

24.01.2026 - CVS Stock was down 5.0%

• The surge in CVS employee bonuses after exceeding profit targets may have initially boosted investor confidence, but the market movement suggests that this positive news was overshadowed by broader market factors.
• The growth projections in the healthcare transportation services market could indicate potential competition or shifting consumer preferences that might have impacted CVS's stock negatively.
• The introduction of new hospital indemnity insurance by Sun Life to address coverage gaps highlights the evolving landscape of healthcare services, potentially signaling increased competition for CVS in the insurance sector.
• The report on the Online Pharmacy market, while not directly related to CVS, could have influenced investor sentiment towards the broader healthcare sector, contributing to the bearish movement in CVS stock.

27.00.2026 - CVS Stock was down 13.2%

• CVS Health's stock experienced a significant drop of about 11.5% after an analyst downgrade and negative news related to Medicare Advantage rates and an antitrust probe into its pharmacy practices.
• The bearish movement in CVS stock could be attributed to concerns about potential impacts on its revenue and profitability due to the proposed flat Medicare Advantage rates by the administration.
• The overall negative sentiment in the healthcare sector, particularly with peers like UnitedHealth, experiencing stock declines and reducing benefits in response to disappointing reimbursement rates, likely added to the downward pressure on CVS Health's stock.
• Despite the challenges, analysts still maintain a "Moderate Buy" rating for CVS Health, indicating some optimism for its future performance despite the current market conditions.

27.00.2026 - CVS Stock was down 11.1%

• The company's price target was reduced to $95 from $100 by an analyst, raising concerns over proposed flat Medicare Advantage rates and an investigation into pharmacy-hub practices, leading to an 11.6% drop in the stock.
• The Trump administration's proposal of near-flat Medicare Advantage reimbursement rates for 2027 negatively affected major health insurers like UnitedHealth and Humana, causing their shares to decline. This announcement also had repercussions on CVS Health's stock.
• Despite positive earnings and strong guidance for FY2025, investor worries surrounding Medicare Advantage rates and ongoing healthcare investigations have overshadowed CVS Health's financial prospects, contributing to the bearish movement.
• Uncertainty surrounding regulations and potential financial impacts on healthcare companies, particularly those heavily dependent on Medicare Advantage plans, has influenced market sentiment and led to a downward trend in CVS Health's stock price.

27.00.2026 - CVS Stock was down 12.5%

• CVS Health experienced a strong bearish movement today, likely influenced by the broader sector-wide selloff due to a proposed near-zero increase in Medicare Advantage payment rates for 2027 by the Trump administration.
• The unexpected regulatory change impacted major health insurers like UnitedHealth Group, CVS Health, and Elevance Health, in addition to Humana, leading to concerns over tighter margins and regulatory uncertainty within the sector.
• Despite CVS Health's positive revenue growth, the challenges it faces with negative financial indicators such as net margin, ROE, ROA, and a high debt-to-equity ratio may have contributed to the market's negative sentiment towards the stock.
• The combination of regulatory concerns in the healthcare sector alongside CVS Health's financial challenges likely played a significant role in the bearish movement of the stock today.

12.01.2026 - CVS Stock was up 5.3%

• CVS stock surged after news of Agree Realty Corporation's strong Q4 performance and increased investment projections, suggesting a robust real estate market.
• The growth of UnitedHealth Group's Optum Health division, alongside a slight decrease in its price target, likely boosted investor confidence in the healthcare sector, positively impacting CVS as a healthcare-related stock.
• With Humana reporting a widened Q4 loss and a projected decline in 2026 EPS, investors may have turned to CVS as a more secure investment within the healthcare industry.
• Dollar Tree's expansion into a former CVS location generated interest in CVS, leading investors to consider the potential effects of evolving retail landscapes on traditional pharmacy chains.

06.04.2026 - CVS Stock was up 6.7%

• CVS Health reported better-than-expected first-quarter results, with total revenue increasing by 6.2% to $100.4 billion and adjusted earnings per share surpassing consensus expectations. This strong performance was primarily driven by robust growth across all operating segments and improved adjusted operating income in its healthcare benefits segment.
• The company raised its full-year earnings guidance and cash flow from operations guidance, indicating confidence in its continued financial strength and growth prospects.
• The increase in Aetna's profits played a significant role in boosting CVS Health's outlook for 2026, highlighting the positive impact of its health insurance arm on the overall financial performance of the company.
• CVS Health's shares jumped 4.1% premarket following the earnings beat and raised guidance, reflecting investor optimism in the company's ability to deliver strong results and navigate challenges in the healthcare industry.

06.04.2026 - CVS Stock was up 7.9%

• CVS Health experienced a strong bullish movement today.
• The positive market movement can be attributed to the company's robust financial performance and positive outlook for the future.
• Factors such as exceeding profit expectations, revenue growth, improved guidance, and strong performance in its insurance and pharmacy divisions contributed to the bullish sentiment.
• The increase in Aetna's profits and the company's focus on simplifying healthcare were key drivers behind the market's positive reaction to CVS's performance.

13.04.2026 - CVS Stock was up 5.0%

• The announcement of successful weight-loss program at CVS clinics, with 85% of patients shedding pounds in 3 months, likely contributed to positive investor sentiment.
• Strong Q1 earnings results, surpassing analyst expectations with revenues of $100.43 billion and adjusted EPS of $2.57, along with raised full-year guidance, boosted confidence in CVS Health Corp's performance.
• The overall positive sentiment in the health insurance sector, as indicated by easing medical costs for major players like CVS, could have further supported the bullish movement in CVS stock.
• Despite the stock being deemed overvalued, the positive news regarding the company's initiatives and financial performance outweighed concerns about valuation, driving the stock price higher.

06.04.2026 - CVS Stock was up 7.2%

• CVS Health Corp. experienced a strong bullish movement today, driven by better-than-expected profits from its Aetna insurance segment and improved performance in its pharmacy business.
• The company raised its earnings outlook for 2026, exceeding analyst expectations, which boosted investor confidence and led to a surge in stock prices.
• Margin improvement in the medical insurance operations, strong growth across all operating segments, and increased adjusted operating income contributed to the positive market sentiment towards CVS.
• Despite facing regulatory challenges and potential benefit cuts for Medicare Advantage plans, CVS's strategic initiatives and confidence in continued growth have positioned the company favorably in the market, leading to the bullish movement.